School of Medicine
Showing 1-10 of 38 Results
Robert K. Jackler, MD
Edward C. and Amy H. Sewall Professor in Otorhinolaryngology and Professor, by courtesy, of Neurosurgery and Surgery
Current Research and Scholarly Interests Tobacco advertising - please see below for details
Clinical: Development of innovative surgical methods, via the cranial base, to expose inaccessible intracranial disease. Surgical simulation and robotics. Evidence based outcomes analysis in acoustic neuroma and other tumors of the cerebellopontine angle.
Medical history - especially the history of otology, neurosurgery, deafness, and quackery.
Peter K. Jackson
Acting Professor, Microbiology & Immunology - Baxter Laboratory
Current Research and Scholarly Interests Cell cycle and cyclin control of DNA replication .
Charlotte D. Jacobs M.D.
Drs. Ben and A. Jess Shenson Professor in the School of Medicine, Emerita
Current Research and Scholarly Interests Clinical Interests: general oncology, sarcomas. Research Interests: clinical trials in solid tumors.
Richard A. Jaffe
Professor of Anesthesiology, Perioperative and Pain Medicine and, by courtesy, of Neurosurgery at the Stanford University Medical Center
Current Research and Scholarly Interests My clinical and laboratory research activities are currently focused on developing new and sensitive means for detecting the onset of cerebral ischemia using both electrophysiological and advanced optical techniques.
Michelle L. James
Instructor, Radiology - Diagnostic Radiology
Current Research and Scholarly Interests My research is focused on developing and evaluating molecular imaging agents for visualizing neurological diseases in living subjects.
Rex L. Jamison
Professor of Medicine, Emeritus and Academic Secretary to the University
Current Research and Scholarly Interests Patients with advanced chronic kidney disease and end stage kidney disease have high rates of cardiovascular mortality and morbidity. The purpose of the Homocysteine Study was to determine if lowering their high plasma homocysteine levels would reduce their mortality. Secondary endpoints included reductions in myocardial infarction, stroke, and amputation of a lower extremity. The results showed there was no improvement in survival or reduction in the cardiovascular events.